SPP635

Speedel Pharma Ltd. · Phase 2 active Small molecule

At a glance

Generic name	SPP635
Sponsor	Speedel Pharma Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria (PHASE2)
Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SPP635 CI brief — competitive landscape report
SPP635 updates RSS · CI watch RSS
Speedel Pharma Ltd. portfolio CI